Pure Transplant Solutions, LLC and Oxford Immunotec, Ltd. Announce Exclusive Sublicense Agreement to Support Commercialization of Novel B Cell Measurement Assay for Early Detection of Tissue Injury and Prevention of Organ Rejection

AUSTIN, Texas and OXFORD, U.K., Dec. 7, 2021 (SEND2PRESS NEWSWIRE) -- Pure Transplant Solutions, LLC (PTS), a developer of novel HLA based transplant diagnostics, and Oxford Immunotec, Ltd. (OI), a global diagnostics company part of PerkinElmer Inc., today announce an exclusive sublicense agreement in which PTS will obtain exclusive commercial rights to issued patents protecting a novel assay originally developed by Dr. Oriol Bestard, M.D., Ph.D. - News from Pure Transplant Solutions LLC, issued by Send2Press Newswire

Related Keywords

China ,Japan ,United States ,Spain ,Texas ,Barcelona ,Comunidad Autonoma De Cataluna ,Oxford Immunotec ,Peter Wrighton Smith ,Blake Harlan ,Oriol Bestard ,Emergent Technologies Inc ,Kidney International ,Pure Protein ,Bellvitge Biomedical Research Institute ,Pure Transplant Solutions ,Drug Administration ,Perkinelmer Inc ,Research Use ,University Of Oklahoma ,Panel Of Reactive Antibody ,Panel Of Reactive Antibodies ,Oxford Immunotec Ltd ,Pure Transplant ,Research Use Only ,Reactive Antibodies ,Donor Specific Antibody ,Human Leucocyte Antigens ,Reactive Antibody ,Transplant Solutions ,Emergent Technologies ,Quality Management System ,Transplant Physicians ,Perkinelmer ,